Finance - Lending
12 recent notes from companies in this sector. 7 companies tracked.
PFC does a second US$300M note in a month, this time floating
After a fixed-rate 5.32% issuance in June, PFC prices US$300M floating-rate notes due 2029 at SOFR+110 bps, a routine funding move for the large PSU NBFC.
Satin Creditcare Q1 AUM at ₹16,000 cr; promoter infuses ₹100 cr at 17% premium
Disbursements surge 54% YoY to ₹3,453 cr, credit costs drop to 2.5-3.0% from 6%, and the promoter puts in ₹100 cr equity — a rare combination for a small-cap NBFC.
Brickwork lifts TFCI NCD rating to AA- as AUM grows 24%, NPAs stay nil
The upgrade was widely telegraphed after audited results and an Infomerics action; market impact is limited.
PFC board approves REC merger at 88:100 swap
Power Finance Corporation will absorb REC, creating a combined loan book of over ₹11 lakh crore. The swap ratio of 88 PFC shares per 100 REC shares is now set, pending approvals.
REC board clears merger with PFC at 0.88:1 swap ratio
The all-stock deal will dissolve REC, creating a dominant power-sector lender with a combined balance sheet. PFC, which already holds 52.63%, will issue new equity to the remaining shareholders.
Goldline promoter lifts stake to 29.27% with open-market buy
Swapan Khandelwal bought 60,000 shares (0.62% of equity) on 22 June. No pledging. For a nano-cap with a market cap of just ₹42 cr, it's a rare vote of confidence.
PFC raises US$300M via 5.32% notes due 2031
The state-run lender priced the bonds under its US$8B MTN programme; proceeds will follow RBI borrowing guidelines.
Satin Creditcare to consider ₹5,000 cr NCD raise — nearly double its market cap
The microfinance lender's board will meet on June 23 to evaluate a debt raise worth 192% of its market capitalisation, dwarfing all prior issuances and signaling a potential strategic shift.
President clears REC merger into PFC, creating a ₹10 lakh crore lending giant.
The biggest regulatory hurdle is cleared. What's left is the money: agreeing on a share-swap ratio that satisfies both sets of shareholders.
Goldline Pharmaceutical's profit jumps 45% to ₹411.71 lacs in FY26
The nano-cap drugmaker's first full-year audited results show profit outpacing revenue growth. Revenue rose 11% to ₹3,119.76 lacs.
Finbud Financial Services targets ₹1,000 cr revenue by FY30
Management set ambitious growth targets for FY27 and beyond, but internal contradictions on margins and loan disbursements clouded the outlook.
Vertis Infrastructure Trust outlines FY26 performance, starts listing process
The infrastructure trust reported portfolio expansion and traffic outperformance, but flagged macro headwinds including bitumen costs. A public listing process has begun without a timeline.